Join our webinar!

How Can Precision Medicine, Genetic Testing, and Biomarkers Support Better Healthcare Decisions?

18 June 2026 | 9:00–10:00 CET

Join us for an ASCERTAIN webinar exploring how genetic testing and biomarker profiling are transforming healthcare and enabling more personalized treatment strategies, particularly in oncology.

This session brings together health economists, HTA experts, and a patient representative to examine these technologies from multiple angles. We will cover the economic evaluation of diagnostics, including next-generation genomic sequencing (NGS), and discuss how different efficiency metrics can inform decisions about their adoption. We will then turn to how biomarkers are used to evaluate treatments in settings where randomized trial evidence is limited or absent – a growing challenge for payers and decision-makers. Speakers will also reflect on what these developments mean for HTA processes and reimbursement decisions in cancer care, before closing with a patient perspective on the value of more testing: when is it wanted, and what does it actually deliver?

Drawing on research and experiences from the ASCERTAIN project, the session will highlight how transparent and adaptable modelling approaches can support equitable access to innovative health technologies.

Zoom Link

The webinar will be hosted on Zoom. You will receive a link in the confirmation email.

Contact

If you have any questions about the webinar, please contact Eline Aas at on.oiu.nisidem@saa.enile

Contributors

Eline Aas
Eline Aas is Professor at the Department of Health Management and Health Economics at the University of Oslo and holds a joint position at the Norwegian Institute of Public Health. Her research focuses on health economic evaluations, decision-analytic modelling, register data analysis, and precision cancer medicine. She has extensive experience evaluating innovative healthcare interventions across several clinical areas.

Benjamin Peter Geisler
Benjamin Peter Geisler is a Doctoral Research Fellow at the Department of Health Management and Health Economics at the University of Oslo. His work focuses on health economic analysis and the evaluation of innovative health technologies.

Kine Pedersen
Kine Pedersen is Associate Professor at the Department of Health Management and Health Economics at the University of Oslo. Her work focuses on economic evaluation of healthcare interventions, disease simulation modelling, prevention and screening, and precision cancer medicine. She also teaches courses in economic evaluation and research design.

Mirjana Huic
Mirjana Huic is a medical doctor and specialist in clinical pharmacology and toxicology with extensive experience in health technology assessment (HTA). She has contributed to numerous EUnetHTA collaborations and European HTA reports covering a broad range of health technologies. She currently works as an independent HTA specialist and expert for several European health initiatives.

Monica Racovita
Monica Racovita is Access and Policy Manager at Myeloma Patients Europe (MPE). She has extensive experience in health and science policy, with a particular focus on cancer policy, healthcare innovation, and patient access to healthcare.